OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tree-Based Model for Thyroid Cancer Prognostication
Mousumi Banerjee, Daniel G. Muenz, Joanne T. Chang, et al.
The Journal of Clinical Endocrinology & Metabolism (2014) Vol. 99, Iss. 10, pp. 3737-3745
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It?
Ian Ganly, Iain J. Nixon, Laura Y. Wang, et al.
Thyroid (2015) Vol. 25, Iss. 10, pp. 1106-1114
Open Access | Times Cited: 166

Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer
Megan R. Haymart, Mousumi Banerjee, David Reyes‐Gastelum, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 104, Iss. 3, pp. 785-792
Open Access | Times Cited: 125

Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems
Mohamed A. Adam, Samantha M. Thomas, Terry Hyslop, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 36, pp. 4415-4420
Open Access | Times Cited: 124

Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study
Debbie Chen, Grant Carr, Francis P. Worden, et al.
Thyroid (2024) Vol. 34, Iss. 7, pp. 837-845
Closed Access | Times Cited: 10

Worry in Thyroid Cancer Survivors with a Favorable Prognosis
Maria Papaleontiou, David Reyes‐Gastelum, Brittany Gay, et al.
Thyroid (2019) Vol. 29, Iss. 8, pp. 1080-1088
Open Access | Times Cited: 74

Cut Points for Clinical Muscle Weakness Among Older Americans
Kate A. Duchowny, Mark D. Peterson, Philippa Clarke
American Journal of Preventive Medicine (2017) Vol. 53, Iss. 1, pp. 63-69
Open Access | Times Cited: 66

Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study
Palak Choksi, Maria Papaleontiou, Cui Guo, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 4, pp. 1254-1260
Open Access | Times Cited: 66

Controversies in the Management of Low-Risk Differentiated Thyroid Cancer
Megan R. Haymart, Nazanene H. Esfandiari, Michael T. Stang, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 4, pp. 351-378
Open Access | Times Cited: 66

Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients
Joshua J. Gruber, A. Dimitrios Colevas
The Oncologist (2015) Vol. 20, Iss. 2, pp. 113-126
Open Access | Times Cited: 65

Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence
Sona Shah, Laura Boucai
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 103, Iss. 2, pp. 689-697
Open Access | Times Cited: 65

Thyroid – Differentiated and Anaplastic Carcinoma

Springer eBooks (2016)
Closed Access | Times Cited: 63

Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid Cancer
Viktoria Florentine Koehler, Pia Adam, Karin Frank‐Raue, et al.
Thyroid (2020) Vol. 31, Iss. 3, pp. 459-469
Closed Access | Times Cited: 50

Disparities in risk perception of thyroid cancer recurrence and death
Debbie Chen, David Reyes‐Gastelum, Lauren P. Wallner, et al.
Cancer (2019) Vol. 126, Iss. 7, pp. 1512-1521
Open Access | Times Cited: 41

Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
Arnaud Jannin, Livia Lamartina, C. Moutarde, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2401-2413
Open Access | Times Cited: 19

Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules
Mayumi Endo, Jing Peng, Fadi Nabhan, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 9, pp. 2317-2324
Closed Access | Times Cited: 4

Creating Prognostic Systems for Well-Differentiated Thyroid Cancer Using Machine Learning
Charles Yang, Lauren Gardiner, Huan Wang, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 35

The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice
Krzysztof Kaliszewski, Dorota Diakowska, Łukasz Nowak, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 24

Isthmusectomy in selected patients with well‐differentiated thyroid carcinoma
Hakyoung Park, Victoria Harries, Marlena McGill, et al.
Head & Neck (2019) Vol. 42, Iss. 1, pp. 43-49
Open Access | Times Cited: 25

Practice patterns for surgical management of low-risk papillary thyroid cancer from 2014 to 2019: A CESQIP analysis
Sean M. Wrenn, Tracy Wang, Asmae Toumi, et al.
The American Journal of Surgery (2020) Vol. 221, Iss. 2, pp. 448-454
Closed Access | Times Cited: 23

Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population
Lujiao Yu, Hong Hong, Jinyu Han, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 16

Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer
Hanqing Zhao, Ying Huang, Guoshun Tong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16188-16188
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top